Details of the Drug | DrugMAP

General Information of Drug (ID: DMBLASN)

Drug Name

DCVax-Ovarian

Synonyms

DCVax-L; Dendritic cell-based immunotherapy (ovarian cancer), Northwest Biotherapeutics

Indication

Disease Entry	ICD 11	Status	REF
Brain cancer	2A00	Phase 3	[1]
Pain	MG30-MG3Z	Phase 3	[2]
Recurrent glioblastoma	2A00.00	Phase 3	[3]
Ovarian cancer	2C73	Phase 1	[4]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D02XEI

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT00045968) Study of a Drug [DCVax-L] to Treat Newly Diagnosed GBM Brain Cancer. U.S. National Institutes of Health.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)